Scott L Lipnick
Overview
Explore the profile of Scott L Lipnick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
479
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ximerakis M, Holton K, Giadone R, Ozek C, Saxena M, Santiago S, et al.
Nat Aging
. 2025 Jan;
5(2):333.
PMID: 39881191
No abstract available.
2.
Beaulieu-Jones B, Frau F, Bozzi S, Chandross K, Peterschmitt M, Cohen C, et al.
NPJ Parkinsons Dis
. 2024 Mar;
10(1):58.
PMID: 38480700
Characterization of Parkinson's disease (PD) progression using real-world evidence could guide clinical trial design and identify subpopulations. Efforts to curate research populations, the increasing availability of real-world data, and advances...
3.
Beaulieu-Jones B, Frau F, Bozzi S, Chandross K, Peterschmitt M, Cohen C, et al.
medRxiv
. 2024 Feb;
PMID: 38405736
Characterization of Parkinson's disease (PD) progression using real-world evidence could guide clinical trial design and identify subpopulations. Efforts to curate research populations, the increasing availability of real-world data and recent...
4.
Ximerakis M, Holton K, Giadone R, Ozek C, Saxena M, Santiago S, et al.
Nat Aging
. 2023 Apr;
3(3):327-345.
PMID: 37118429
Aging is a complex process involving transcriptomic changes associated with deterioration across multiple tissues and organs, including the brain. Recent studies using heterochronic parabiosis have shown that various aspects of...
5.
Yuan W, Beaulieu-Jones B, Krolewski R, Palmer N, Veyrat-Follet C, Frau F, et al.
BMC Neurol
. 2021 May;
21(1):201.
PMID: 34006233
Background: Characterization of prediagnostic Parkinson's Disease (PD) and early prediction of subsequent development are critical for preventive interventions, risk stratification and understanding of disease pathology. This study aims to characterize...
6.
Finlayson S, McDermott M, Pickering A, Lipnick S, Kohane I
Pac Symp Biocomput
. 2021 Mar;
26:273-284.
PMID: 33691024
Modeling the relationship between chemical structure and molecular activity is a key goal in drug development. Many benchmark tasks have been proposed for molecular property prediction, but these tasks are...
7.
Yuan W, Beaulieu-Jones B, Yu K, Lipnick S, Palmer N, Loscalzo J, et al.
Nat Commun
. 2021 Feb;
12(1):1107.
PMID: 33597541
One of the primary tools that researchers use to predict risk is the case-control study. We identify a flaw, temporal bias, that is specific to and uniquely associated with these...
8.
Ximerakis M, Lipnick S, Innes B, Simmons S, Adiconis X, Dionne D, et al.
Nat Neurosci
. 2019 Sep;
22(10):1696-1708.
PMID: 31551601
The mammalian brain is complex, with multiple cell types performing a variety of diverse functions, but exactly how each cell type is affected in aging remains largely unknown. Here we...
9.
Yang S, Lipnick S, Makhortova N, Venugopalan S, Fan M, Armstrong Z, et al.
SLAS Discov
. 2019 Jul;
24(8):829-841.
PMID: 31284814
The etiological underpinnings of many CNS disorders are not well understood. This is likely due to the fact that individual diseases aggregate numerous pathological subtypes, each associated with a complex...
10.
Lipnick S, Agniel D, Aggarwal R, Makhortova N, Finlayson S, Brocato A, et al.
PLoS One
. 2019 Mar;
14(3):e0213680.
PMID: 30870495
Objective: We investigated the presence of non-neuromuscular phenotypes in patients affected by Spinal Muscular Atrophy (SMA), a disorder caused by a mutation in the Survival of Motor Neuron (SMN) gene,...